drugset / Trial / NCT00304499
Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the side-effect profile and efficacy of sustained release, OROS® and TTS, dosage forms of oxybutynin with immediate release (IR) oral oxybutynin and with placebo.
Timeline
- Start
- 1995-12
- Primary completion
- —
- Completion
- 1996-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxybutynin | Small molecule | 1.7 mg | Oral |
| Subject | Oxybutynin | Small molecule | 2.5 mg | Oral |
Indications
No indication recorded.